| Description |
1 online resource |
| Contents |
Title page; Table of Contents; Preface; Acknowledgements; Notes on using The Maudsley Prescribing Guidelines; Notes on inclusion of drugs; List of abbreviations; Chapter 1: Plasma level monitoring of psychotropic drugs; Interpreting sample results; References; Acting on clozapine plasma concentration results; References; Interpreting post-mortem blood concentrations; References; Chapter 2: Schizophrenia; ANTIPSYCHOTIC DRUGS; General introduction; References; General principles of prescribing; References; Minimum effective doses; References; Further reading |
|
Quick reference for licensed maximum dosesEquivalent doses; References; High-dose antipsychotics: prescribing and monitoring; References; Antipsychotic prophylaxis; References; Combined antipsychotics; References; Negative symptoms; References; Monitoring; References; Relative adverse effects -- a rough guide; Treatment algorithms for schizophrenia; References; First-generation antipsychotics -- place in therapy; References; Omega-3 fatty acid (fish oils) in schizophrenia; References; New and developing drugs to treat schizophrenia; References |
|
NICE guidelines for the treatment of schizophrenia1References; Antipsychotic response -- to increase the dose, to switch, to add or just wait -- what is the right move?; References; Antipsychotic long-acting injections; References; Further reading; Depot antipsychotics -- pharmacokinetics; References; Management of patients on long-term depots; References; Aripiprazole LAI; References; Olanzapine LAI; References; Paliperidone palmitate LAI; References; Risperidone LAI; References; ANTIPSYCHOTICS -- ADVERSE EFFECTS; Extrapyramidal side-effects; References; Further reading; Akathisia; References |
|
Further readingWeight gain; References; Treatment of drug-induced weight gain; References; Tardive dyskinesia; References; Further reading; Neuroleptic malignant syndrome; References; Catatonia; References; QT prolongation; References; Further reading; Dyslipidaemia; References; Diabetes and impaired glucose tolerance; References; Hypertension; References; Hyponatraemia; References; Hyperprolactinaemia; References; Sexual dysfunction; References; Pneumonia; References; Switching antipsychotics; References; REFRACTORY SCHIZOPHRENIA AND CLOZAPINE; Clozapine -- dosing regimen; References |
|
Optimising clozapine treatmentReferences; Further reading; Alternatives to clozapine; References; Re-starting clozapine after a break in treatment; Reference; Initiation of clozapine for community-based patients; Further reading; CLOZAPINE -- ADVERSE EFFECTS; Common adverse effects; References; Further reading; Clozapine: uncommon or unusual adverse effects; References; Clozapine: serious haematological and cardiovascular adverse effects; References; Further reading; Clozapine-induced hypersalivation; References; Further reading; Clozapine-induced gastrointestinal hypomotility (CIGH) |
| Summary |
The fully updated 12th edition of an essential reference for anyone responsible for prescribing drugs for patients with mental health disorders. A well-respected and widely-used source of information on which drugs to prescribe, which side effects to look out for, how best to augment or switch drugs, and more Provides concise reviews of psychiatric disorders and relevant psychopharmacology, along with general guidance based on the data reviewed and current clinical practice Includes specific guidance for schizophrenia, bipolar disorder, depression, anxiety, substance abuse, and special populations such as children, the elderly and pregnant women Each section features a full reference list so the evidence base can be checked quickly and easily |
| Bibliography |
Includes bibliographical references and index |
| Notes |
Print version record and CIP data provided by publisher |
| Subject |
Mental illness -- Chemotherapy
|
|
Psychopharmacology -- Great Britain
|
|
Psychotropic drugs -- Administration
|
|
Psychotropic drugs -- Therapeutic use
|
|
Mental illness -- Chemotherapy -- Great Britain
|
|
Psychotropic drugs -- Therapeutic use -- Great Britain
|
|
Mental Disorders -- drug therapy
|
|
Psychopharmacology -- methods
|
|
Psychotropic Drugs -- administration & dosage
|
|
Psychotropic Drugs -- therapeutic use
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Mental illness -- Chemotherapy
|
|
Psychopharmacology
|
|
Psychotropic drugs -- Therapeutic use
|
| SUBJECT |
United Kingdom https://id.nlm.nih.gov/mesh/D006113 |
| Subject |
Great Britain
|
| Form |
Electronic book
|
| Author |
Paton, Carol, author.
|
|
Kapur, Shitij, author.
|
|
South London and Maudsley NHS Trust, issuing body.
|
| LC no. |
2014049897 |
| ISBN |
9781118754573 |
|
1118754573 |
|
9781118754597 |
|
111875459X |
|
1118754603 |
|
9781118754603 |
|
